NCT07021807View on ClinicalTrials.gov

ANC COVID-19 Surveillance

CompletedOBSERVATIONAL
Enrollment

9,111

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

March 30, 2023

Conditions
SARS-CoV-2 Seroprevalence
Trial Locations (1)

10101

Centre for Infectious Disease Research in Zambia, Lusaka

All Listed Sponsors
lead

Centre for Infectious Disease Research in Zambia

OTHER

NCT07021807 - ANC COVID-19 Surveillance | Biotech Hunter | Biotech Hunter